Selective increase in serum IgE following enfuvirtide administration in HIV-1 infected multidrug resistant patients

Autor:	Hamid Hasson, Biswas P, Galli L, Se, Burastero, Danise A, Bigoloni A, Carini E, Locatelli M, Vecchi A, Lazzarin A, Castagna A
Přispěvatelé:	Hasson, Hamid, Biswas, Priscilla, Galli, Laura, Burastero Samuele, E., Danise, Anna, Bigoloni, Alba, Carini, Elisabetta, Locatelli, Massimo, Vecchi, Andrea, Lazzarin, Adriano, Castagna, Antonella
Rok vydání:	2007
Předmět:	Adult Male HIV Infections Enfuvirtide Immunoglobulin E Middle Aged HIV Envelope Protein gp41 Peptide Fragments CD4 Lymphocyte Count Drug Resistance Multiple Viral HIV Fusion Inhibitors HIV-1 Humans Female
Zdroj:	Scopus-Elsevier Europe PubMed Central
ISSN:	1121-7138
Popis:	Enfuvirtide (ENF) is the first HIV-1 entry inhibitor used in clinical practice and is currently administered via the subcutaneous route. We here evaluated whether ENF administration leads to a change in humoral parameters, including IgE, possibly related to ENF-associated injection site reactions (ISRs). A 24-week prospective study was conducted in multidrug resistant patients enrolled in the ENF Early Access Program characterized by CD4 counts
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::434e529fef3233884f187f53772d435e https://pubmed.ncbi.nlm.nih.gov/17201088 Zobrazit plný text záznamu